Serum and serum-derived extracellular vesicle microRNA signatures linked to neurodevelopmental processes in central precocious puberty - Top-Institutions - MDSpire

Serum and serum-derived extracellular vesicle microRNA signatures linked to neurodevelopmental processes in central precocious puberty

  • By

  • Maria Morrou

  • Vassos Neocleous

  • Meropi Toumba

  • Marios Tomazou

  • Louiza Potamiti

  • Maria Zanti

  • Kyriaki Michailidou

  • Fotios Mpekris

  • George M. Spyrou

  • Andreas Protopapas

  • Elena Sotiriou

  • Michalis Iasonides

  • Nicos Skordis

  • Pavlos Fanis

  • Leonidas A. Phylactou

  • July 10, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pediatrics
    • Endocrinology

  • #2

    Children’s Hospital of Philadelphia
    Children’s Hospital of Philadelphia

    Philadelphia, Pennsylvania

    Key Differentiators

    • Pediatrics
    • Endocrinology

  • #3

    Oulu University Hospital
    Oulu University Hospital

    Oulu, Finland

    Key Differentiators

    • Pediatrics
    • Endocrinology

  • #4

    Shenzhen Maternity & Child Healthcare Hospital
    Shenzhen Maternity & Child Healthcare Hospital

    Shenzhen, China

    Key Differentiators

    • Pediatrics
    • Endocrinology

  • #5

    Copenhagen Puberty Study
    Copenhagen Puberty Study

    Copenhagen, Denmark

    Key Differentiators

    • Pediatrics
    • Endocrinology

Original Source(s)

Serum and serum-derived extracellular vesicle microRNA signatures linked to neurodevelopmental processes in central precocious puberty

  • by Maria Morrou, Vassos Neocleous, Meropi Toumba, Marios Tomazou, Louiza Potamiti, Maria Zanti, Kyriaki Michailidou, Fotios Mpekris, George M. Spyrou, Andreas Protopapas, Elena Sotiriou, Michalis Iasonides, Nicos Skordis, Pavlos Fanis, Leonidas A. Phylactou

  • July 10, 2026

Related Content

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

Differential immunologic response to GnRHa alone vs. dual trigger for final follicular maturation: a proof-of-concept pilot study

Therapeutic monoclonal antibodies for diabetic kidney disease: a narrative review from basic mechanisms to clinical evidence